Active ingredientIndinavirCat. No. P-I041-001CAS 150378-17-9Family · Pharmaceutical analytical standards
Indinavir
An HIV protease inhibitor approved in the United States in 1996: combined with two nucleoside reverse transcriptase inhibitors, it helped set a new standard for combination antiretroviral therapy. This family brings together the active ingredient and labelled standards.
Did you know?Its design drew on the three-dimensional structure of HIV protease published in 1989, and the FDA approved it just 42 days after the application was filed.
Go to the active ingredient →Active ingredientIndinavirCat. No. P-I041-001CAS 150378-17-9
Active ingredientIndinavir SulfateCat. No. P-I041-002CAS 157810-81-6
Isotopically labelledIndinavir-d6Cat. No. P-I041-003CAS 185897-02-3No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceIndinavir CRSEDQM code Y0000788Family IndinavirNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.